Vertex Pharmaceuticals, Inc. (VRTX)

476.90 +7.63 (+1.63%) USD  |  NASDAQ  |  Feb 20, 16:00
476.85 -0.05 (-0.01%) After-Hours: 20:00
More

Vertex Pharmaceuticals Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for VRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
Moderna, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Eli Lilly & Co. --
Merck & Co., Inc. --
Pfizer Inc. --